New evidence on the costing the delivery of COVID-19 vaccines in Mozambique and the Philippines

ThinkWell has released two new reports on the cost of delivering COVID-19 vaccines in Mozambique and the Philippines, aiming to support governments and address the knowledge gap on the cost of these vaccination programs. In partnership with the Universidade Eduardo Mondlane and Ateneo de Manila University, ThinkWell conducted retrospective, bottom-up costing studies, as well as qualitative assessments of operational and financial bottlenecks.

In Mozambique, the financial cost per dose delivered was $0.96 during the initial roll-out period when vaccine supply was limited, and $0.43 per dose during a later period when the program had ramped up (December 2021 to February 2022). The low financial cost found by our study reflects inadequate  funding as opposed to the program being inexpensive to implement. Even in areas that were donor-supported like transport and per diem, funding fell short, and due to pre-existing health worker shortages, the C19 vaccination roll-out may have caused disruptions to other health services.

In the Philippines, the financial unit cost was much higher, at $1.43 per dose during the first mass campaign (National Vaccination Day), and $2.42 during a later period of routine-style delivery, though the cost varied widely across types of vaccination sites. Unlike many other countries, the Philippines was able to rapidly mass hire additional health workers, which alleviated health worker shortages but drove up the financial cost.

You can read the full findings and methods in the reports for Mozambique and the Philippines.

These studies are part of multi-country project that utilizes standardized methods to generate cost evidence on the delivery of C19 vaccines in low- and middle-income countries. Findings from Côte d’Ivoire and Vietnam are already available, and the reports from Bangladesh, Democratic Republic of Congo, and Uganda will be published early next year.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Delivering 270M+ COVID-19 vaccines at just $0.29 per dose: The Bangladesh experience

Bangladesh launched its COVID-19 vaccination program in February 2021 with the ambitious aim of reaching 80% of the population with two doses. The program used a phased approach, initially targeting priority groups, and expanding eligibility over time as supply ramped up. By June 2022, the country had achieved its goal—having delivered over 270 million COVID-19 … Read More

Call for resources: ThinkWell is inviting researchers to submit evidence on the cost of delivering immunization services

The Immunization Delivery Cost Catalogue (IDCC) is the most comprehensive, standardized global evidence on the cost of delivering vaccines, covering 317 unit costs from 68 studies published between 2005 and early 2019. The IDCC supports global and country immunization stakeholders in answering the question: “What are the unit costs of vaccine delivery across different low … Read More

Submissions Open for Special Issue of Vaccines on Estimating Vaccines’ Value and Impact

Estimating the value and public health impact of vaccines is critical to ensure evidence-based policy decision making in nearly all stages, from vaccine development to the introduction/implementation of vaccines in low-resource settings. To foster public health equity, as well as estimate value to local and national economies, concerted efforts are needed to increase the understanding … Read More